Alteration of antioxidants during the progression of heart disease in streptozotocin-induced diabetic rats. 2001

K Doi, and F Sawada, and G Toda, and S Yamachika, and S Seto, and Y Urata, and Y Ihara, and N Sakata, and N Taniguchi, and T Kondo, and K Yano
Third Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki 852-8501, Japan.

Involvement of oxidative stress is implicated in the progression of complication of diabetes mellitus. With respect to heart diseases, we have studied role of oxidative stress/antioxidants using rats treated with streptozotocin to induce diabetes (DM). Hemodynamic and echocardiographic measurements showed thickening of the wall and an increase in the internal dimension of the left ventricle (LV) in DM rats at 8th week. Decrease in diastolic posterior wall velocity and rate of LV pressure change, and increase in LV end diastolic pressures also proved cardiac dysfunction. These changes were further developed in DM rats after 12 weeks. Utilizing rat hearts at 8th and 12th weeks, the following estimations were performed. There was a decrease in the activity of Mn-superoxide dismutase (SOD), suggesting abnormal mitochondrial metabolism of reactive oxygen species. The level of glutathione (GSH) decreased concomitant with a decrease in the expression of gamma-glutamylcysteine synthetase (gamma-GCS). The expression of transforming growth factor-beta1 (TGF-beta1), known as a growth factor and a suppressor of GSH synthesis, elevated in DM rat hearts. Immunohistochemical estimation showed an increase in type IV collagen in DM hearts. Collectively, it was suggested a linkage between mitochondrial damage to generate reactive oxygen species and inactivation of Mn-SOD and elevation of the expression of TGF-beta1 to lead suppression of GSH synthesis and induction of fibrous change for the consequent cardiac dysfunction in DM.

UI MeSH Term Description Entries
D008297 Male Males
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005721 Glutamate-Cysteine Ligase One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of gamma-glutamylcysteine from glutamate and cysteine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.2. gamma-Glutamyl-Cysteine Synthetase,Glutamylcysteine Synthetase,Glutamate Cysteine Ligase,Ligase, Glutamate-Cysteine,Synthetase, Glutamylcysteine,Synthetase, gamma-Glutamyl-Cysteine,gamma Glutamyl Cysteine Synthetase
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006352 Heart Ventricles The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation. Cardiac Ventricle,Cardiac Ventricles,Heart Ventricle,Left Ventricle,Right Ventricle,Left Ventricles,Right Ventricles,Ventricle, Cardiac,Ventricle, Heart,Ventricle, Left,Ventricle, Right,Ventricles, Cardiac,Ventricles, Heart,Ventricles, Left,Ventricles, Right
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

K Doi, and F Sawada, and G Toda, and S Yamachika, and S Seto, and Y Urata, and Y Ihara, and N Sakata, and N Taniguchi, and T Kondo, and K Yano
April 2014, Indian journal of clinical biochemistry : IJCB,
K Doi, and F Sawada, and G Toda, and S Yamachika, and S Seto, and Y Urata, and Y Ihara, and N Sakata, and N Taniguchi, and T Kondo, and K Yano
June 2010, Phytotherapy research : PTR,
K Doi, and F Sawada, and G Toda, and S Yamachika, and S Seto, and Y Urata, and Y Ihara, and N Sakata, and N Taniguchi, and T Kondo, and K Yano
June 2010, Journal of cardiovascular pharmacology and therapeutics,
K Doi, and F Sawada, and G Toda, and S Yamachika, and S Seto, and Y Urata, and Y Ihara, and N Sakata, and N Taniguchi, and T Kondo, and K Yano
February 2012, Journal of cardiovascular pharmacology,
K Doi, and F Sawada, and G Toda, and S Yamachika, and S Seto, and Y Urata, and Y Ihara, and N Sakata, and N Taniguchi, and T Kondo, and K Yano
August 2011, International journal of molecular medicine,
K Doi, and F Sawada, and G Toda, and S Yamachika, and S Seto, and Y Urata, and Y Ihara, and N Sakata, and N Taniguchi, and T Kondo, and K Yano
August 2013, Phytotherapy research : PTR,
K Doi, and F Sawada, and G Toda, and S Yamachika, and S Seto, and Y Urata, and Y Ihara, and N Sakata, and N Taniguchi, and T Kondo, and K Yano
August 2019, Journal of biochemical and molecular toxicology,
K Doi, and F Sawada, and G Toda, and S Yamachika, and S Seto, and Y Urata, and Y Ihara, and N Sakata, and N Taniguchi, and T Kondo, and K Yano
January 2012, Molecular vision,
K Doi, and F Sawada, and G Toda, and S Yamachika, and S Seto, and Y Urata, and Y Ihara, and N Sakata, and N Taniguchi, and T Kondo, and K Yano
February 2008, Autonomic neuroscience : basic & clinical,
K Doi, and F Sawada, and G Toda, and S Yamachika, and S Seto, and Y Urata, and Y Ihara, and N Sakata, and N Taniguchi, and T Kondo, and K Yano
December 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
Copied contents to your clipboard!